DaVita
DVA
#1807
Rank
NZ$20.39 B
Marketcap
NZ$324.22
Share price
-2.82%
Change (1 day)
55.86%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$21.72

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$22.19. In 2025 the company made an earnings per share (EPS) of NZ$17.99 a decrease over its 2024 EPS that were of NZ$19.61.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$21.7220.73%
2025NZ$17.99-8.25%
2024NZ$19.6144.94%
2023NZ$13.5327.26%
2022NZ$10.63-35.56%
2021NZ$16.5044.1%
2020NZ$11.4519.7%
2019NZ$9.57540.48%
2018NZ$1.49-76.07%
2017NZ$6.24-19.31%
2016NZ$7.73242.52%
2015NZ$2.26-62.87%
2014NZ$6.0813.43%
2013NZ$5.368.45%
2012NZ$4.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$44.15 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$21.64-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$46.44 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.76-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA